UC Riverside study focused on farm-working communities in California’s Eastern Coachella Valley
SAVE focuses on mutations in SARS-CoV-2 and emerging virus variants
To gauge the impacts of dark mornings in some parts of the country, we spoke with two UC Riverside experts
UC Riverside’s Dr. David Lo, a vaccine expert, shares his thoughts
UC Riverside-led study shows how an effective therapy against SARS-CoV-2 could be developed
An incentive program aims to increase testing compliance and improve campus health at UC Riverside.
UC Riverside-led team develops new computational method that applies techniques from statistical physics mathematical models in epidemiology
New method developed by UC Riverside researchers quickly assesses drug potential for rare disorders
Joint effort by UC Riverside and UCLA scientists aims to stop the COVID-19-spreading virus from attacking immune cells
There's the fear of catching COVID-19, and then there's the anxiety that comes with buying the right mask. UCR experts advise the first pick for face coverings should be the N95 mask, the second the KN95 mask, and the third a combination of the surgical mask worn under a cloth...
UC Riverside-led team identifies a new host protein interaction that produces a robust immune response to viral infection in birds and may lead to better poultry vaccines
As the COVID-19 pandemic continues, the development of antiviral drug treatments has become a critical weapon in our arsenal against the virus. Harnessing the research and scientific brainpower needed to treat and prevent the next pandemic is the University of California - National Labs Antiviral Treatments Targeting All Coronaviruses and...
UC Riverside experts weigh in
Containing the COVID-19 pandemic depends on the degree to which people exhibit prosocial behavior — behavior that benefits others. We wear masks to protect ourselves, but also our neighbors. We get vaccines to stop the spread of the coronavirus, to edge society closer to herd immunity. A new study from...
UC Riverside mouse study focuses on the receptor TNFR1
UC Riverside research shows gene reactivation can be used to treat Fragile X syndrome